NCT06681597 Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans Status COMPLETED Phase EARLY_PHASE1
NCT06681246 The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment Status RECRUITING Phase NA
NCT06680674 Multinational Point Prevalence Study on the Management of Diabesity in Hospitals Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06676605 Impact of Ashwagandha in Obesity Parameters from Mexican Adults Status COMPLETED Phase NA
NCT06673914 EFFECTS OF OLEUROPEIN ON BLOOD PARAMETERS AND INFLAMMATORY MARKERS IN ADULTS WITH METABOLIC SYNDROME Status ACTIVE_NOT_RECRUITING Phase NA
NCT06672939 A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities Status RECRUITING Phase PHASE3
NCT06672549 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) Status RECRUITING Phase PHASE3
NCT06666842 Longitudinal Effects of a Commercial Digital Weight Management Program on Weight Loss Status COMPLETED Phase NA
NCT06665789 Mindfulness-based Stress Reduction in Obese Women With Polycystic Ovary Syndrome (PICOS) Status COMPLETED Phase NA
NCT06664099 Comparison of Weight Loss and Nutritional Deficiency After One Anastomosis Gastric Bypass at 150, 170, and 200 cm From the Duodenojejunal Junction Status COMPLETED Phase NA
NCT06662539 Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities Status COMPLETED Phase PHASE2
NCT06662383 A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06661434 Prevalence of Obesity Among Adult Patients With Congenital Heart Disease: a Population-based Study Status COMPLETED Phase N/A
NCT06649071 Clinical Classification and Imaging Markers in Patients of Obesity Status ENROLLING_BY_INVITATION Phase N/A
NCT06645756 Comparative Analysis of Postprandial Effects in Healthy and Obese Individuals Status COMPLETED Phase NA
NCT06643728 A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight Status ACTIVE_NOT_RECRUITING Phase PHASE2